Published Sep 14, 2026, 4:00 AM ET · Updated 2 months ago · 2 sources
BioNTech Lung Cancer Drug Extends Survival Versus Chemotherapy
bloomberg
·
Original Report
BioNTech SE said its experimental drug gotistobart nearly doubled the median survival of patients with an aggressive form of lung cancer compared to chemotherapy.